PERSPECTA

News from every angle

Back to headlines

Eli Lilly to acquire Ajax Therapeutics for up to $2.3 billion

Pharmaceutical giant Eli Lilly is set to acquire Ajax Therapeutics in a deal potentially valued at up to $2.3 billion, expanding its therapeutic portfolio.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.